Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy

Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy

US Patent 7172749 · Granted Feb 6, 2007

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric proteins for targeting dsRNA2024
Castration resistant prostate cancer2023
Chimeric proteins for targeting dsRNA2022
Radiolabeled erlotinib analogs and uses thereof2020
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2019
IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative2017
Molecular imaging agents2015
Compounds for treatment of cell proliferative diseases2015
2-(2-phenylethenyl) 1,3-benzodiazepine derivatives useful for the treatment of c2015
EGFR-homing double-stranded RNA vector for systemic cancer treatment2015
Quinazoline-based T cell proliferation inhibitors2014
Compounds for treatment of cell proliferative diseases2014